about
sameAs
Penicinillamine for Wilson's diseaseMedical therapeutic agents for Wilson's diseaseAcute liver failure including acetaminophen overdoseClinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort studyDifferential diagnosis of common tremor syndromesReview and evaluation of the methodological quality of the existing guidelines and recommendations for inherited neurometabolic disordersWilson's Disease in China.Truncating mutations in the Wilson disease gene ATP7B are associated with very low serum ceruloplasmin oxidase activity and an early onset of Wilson disease.Liver enzyme alteration: a guide for clinicians.Leptospirosis presenting in a woman with fulminant hepatic failure from Wilson's disease: a case report.Diagnostic criteria for acute liver failure due to Wilson disease.Review article: diagnosis and current therapy of Wilson's disease.The use of selected nutrition supplements and complementary and alternative medicine in liver disease.Various copper and iron overload patterns in the livers of patients with Wilson disease and idiopathic copper toxicosis.Wilson's disease: a comprehensive review of the molecular mechanisms.Laser ablation inductively coupled plasma mass spectrometry imaging of metals in experimental and clinical Wilson's disease.Liver transplantation for Wilson disease.Wilson's disease: an analysis of 28 Brazilian children.Wilson's disease: clinical, genetic and pharmacological findings.A Case of Wilson's Disease in Patient with Mildly Elevated Liver EnzymesAASLD clinical practice guidelines: a critical review of scientific evidence and evolving recommendations.Fourteen Years of Experience of Liver Transplantation for Wilson's Disease; a Report on 107 Cases from Shiraz, IranA case study: identifying a new case of Wilson's disease.Genetic background of Japanese patients with adult-onset storage diseases in the liver.Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests.Gastrointestinal side effects in children with Wilson's disease treated with zinc sulphate.Current concepts in the evaluation of patients for liver transplantation.Inherited metabolic disorders involving the eye: a clinico-biochemical perspective.Medical management of chronic liver diseases in children (part I): focus on curable or potentially curable diseases.Current status in the therapy of liver diseases.Geographic distribution of ATP7B mutations in Wilson disease.ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.Diffuse large B-cell lymphoma causing acute liver failure: a rare case of survivalHemolytic Anemia as a Presenting Feature of Wilson's Disease: A Case Report.Cell Permeable Au@ZnMoS4 Core-Shell Nanoparticles: Towards a Novel Cellular Copper Detoxifying Drug for Wilson's DiseaseWilson's disease masquerading as nonalcoholic steatohepatitis.Liver transplantation for children with Wilson disease: comparison of outcomes between children and adults.Repeated transplantation of hepatocytes prevents fulminant hepatitis in a rat model of Wilson's disease.Screening in liver disease.Limitations of non-ceruloplasmin-bound copper in routine clinical practice.
P2860
Q24201651-150E3E71-3F53-4559-A546-CFAC5E62D160Q24236053-7CD21480-01A7-47A2-9333-4ACC640E868BQ24647134-8BD08193-079F-4742-A59F-9D3238AB8DC7Q24679692-AB0ACB76-255E-492E-970B-A22C87FC6E02Q24680120-E01510DE-B3E5-40D9-84EA-1BBAC3C6773BQ26771677-B2FD6FE9-C9F9-4221-ADDA-8D13EE3F4034Q30235404-5AE25ADE-C790-4308-B4DF-2B7D170B0B78Q33524914-DDEB7886-B06D-400C-AF64-D55DFF859453Q33759637-6FBDA604-5F83-4D91-84FD-9FFC51EDF55BQ34078321-F705B886-E4A9-429C-9A11-9796249E58B9Q34099382-9DC74F4E-D778-4411-90E5-BE802628E172Q34289864-6CDFFAFA-0DC6-4FE5-A43B-34BBEA75EE0AQ34554574-3ABB791A-E4C8-4735-9DB5-51F977CCBF98Q34556776-D7EEA1FC-3B05-4F98-B6F9-506CD875E60EQ35381754-F6A7B061-FD98-44E6-923F-44E1862A2B61Q35391010-7F78BFA9-A6DC-4722-900A-48727AFAA015Q35736533-8F1B1417-EB5F-42E7-8B73-61250BEA00A9Q35813425-925D9118-6593-468F-B712-976A13E08937Q36033407-77D6BAD3-164B-44E6-AA2C-CF0B1413CA77Q36058302-351385B1-D48C-4065-8933-91FBEB7E4BB0Q36185550-2C971894-F678-45E4-BCCC-88882ED21F63Q36216217-A477C5E8-6319-415E-A337-A787B3DF921BQ36315219-6E0708D2-89AE-490A-B3C5-DAB3D1884BE7Q36828253-F04E5AF7-D4C0-4D23-AC29-276BDD32EC51Q36939710-87040261-131C-4AFE-9A6C-4A95E30E68B4Q37034043-38F60A10-37FB-4DA6-8355-531C95354483Q37346009-17505469-2EC9-4076-90BB-044A121488DEQ37607099-7B6C80D5-52C8-4913-A982-E66D47C82A36Q37945752-53ACE8A9-57A9-4B30-82E8-321216880D5EQ38208508-85098341-0B78-434D-8A6B-3A4DA964B3A1Q38553471-A3ADF38B-1282-4969-AE8A-E7C32233257FQ40416496-5A68150D-692F-450E-8066-73C9842C05ECQ40748553-E7A61349-98F4-4EB3-AA70-04EF404C9C37Q41158774-1C550C66-4C56-41A5-A1CD-636BC5D6B93DQ41385070-699DD5CA-1D3E-4A8A-BF1D-F5873EC48268Q42182118-65E2E7E1-6F11-4F1E-9504-46FB16964E12Q42678508-0979E78F-4899-4958-BC8E-0AE50C392841Q42723129-27CDDA58-AD4D-4C21-A2A2-1C113E4987DAQ42726447-B8C4B2D0-66DD-4ECC-9601-4AEB93F9CEF6Q42843644-56A853D8-4088-476A-825A-59734E1F308F
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
A practice guideline on Wilson disease
@ast
A practice guideline on Wilson disease
@en
A practice guideline on Wilson disease
@nl
type
label
A practice guideline on Wilson disease
@ast
A practice guideline on Wilson disease
@en
A practice guideline on Wilson disease
@nl
prefLabel
A practice guideline on Wilson disease
@ast
A practice guideline on Wilson disease
@en
A practice guideline on Wilson disease
@nl
P356
P1433
P1476
A practice guideline on Wilson disease
@en
P2093
Eve A Roberts
Michael L Schilsky
P304
P356
10.1053/JHEP.2003.50252
P407
P577
2003-06-01T00:00:00Z